266 related articles for article (PubMed ID: 22644781)
21. A novel pro-inflammatory mechanism of action of resistin in human endothelial cells: up-regulation of SOCS3 expression through STAT3 activation.
Pirvulescu M; Manduteanu I; Gan AM; Stan D; Simion V; Butoi E; Calin M; Simionescu M
Biochem Biophys Res Commun; 2012 Jun; 422(2):321-6. PubMed ID: 22575502
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-induced SOCS3 is limiting STAT3 phosphorylation and NF-κB activation in congenital heart disease.
Gu Q; Kong Y; Yu ZB; Bai L; Xiao YB
Biochimie; 2011 May; 93(5):909-20. PubMed ID: 21354254
[TBL] [Abstract][Full Text] [Related]
23. Interferon alpha antagonizes STAT3 and SOCS3 signaling triggered by hepatitis C virus.
Zhao LJ; He SF; Wang W; Ren H; Qi ZT
Cytokine; 2016 Apr; 80():48-55. PubMed ID: 26945996
[TBL] [Abstract][Full Text] [Related]
24. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
25. Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation.
Boyle K; Zhang JG; Nicholson SE; Trounson E; Babon JJ; McManus EJ; Nicola NA; Robb L
Cell Signal; 2009 Mar; 21(3):394-404. PubMed ID: 19056487
[TBL] [Abstract][Full Text] [Related]
26. Suppressor of cytokine signaling-3 suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary sensory neurons.
Miao T; Wu D; Zhang Y; Bo X; Subang MC; Wang P; Richardson PM
J Neurosci; 2006 Sep; 26(37):9512-9. PubMed ID: 16971535
[TBL] [Abstract][Full Text] [Related]
27. Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells.
Baus D; Pfitzner E
Int J Cancer; 2006 Mar; 118(6):1404-13. PubMed ID: 16206268
[TBL] [Abstract][Full Text] [Related]
28. Nucleocytoplasmic shuttling of persistently activated STAT3.
Herrmann A; Vogt M; Mönnigmann M; Clahsen T; Sommer U; Haan S; Poli V; Heinrich PC; Müller-Newen G
J Cell Sci; 2007 Sep; 120(Pt 18):3249-61. PubMed ID: 17726064
[TBL] [Abstract][Full Text] [Related]
29. Suppressor of cytokine signaling 3 negative regulation of signal transducer and activator of transcription 3 in platelet-derived growth factor-induced fibroblast migration.
Nagai H; Tokumaru S; Sayama K; Shirakata Y; Hanakawa Y; Hirakawa S; Dai X; Tohyama M; Yang L; Hashimoto K
J Dermatol; 2007 Aug; 34(8):523-30. PubMed ID: 17683382
[TBL] [Abstract][Full Text] [Related]
30. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
[TBL] [Abstract][Full Text] [Related]
31. SOCS3 suppresses AP-1 transcriptional activity in neuroblastoma cells through inhibition of c-Jun N-terminal kinase.
Miao T; Wu D; Zhang Y; Bo X; Xiao F; Zhang X; Magoulas C; Subang MC; Wang P; Richardson PM
Mol Cell Neurosci; 2008 Feb; 37(2):367-75. PubMed ID: 18055217
[TBL] [Abstract][Full Text] [Related]
32. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
Haura EB; Zheng Z; Song L; Cantor A; Bepler G
Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
[TBL] [Abstract][Full Text] [Related]
33. Identification of STAT3 as a specific substrate of breast tumor kinase.
Liu L; Gao Y; Qiu H; Miller WT; Poli V; Reich NC
Oncogene; 2006 Aug; 25(35):4904-12. PubMed ID: 16568091
[TBL] [Abstract][Full Text] [Related]
34. SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation.
Lindemann C; Hackmann O; Delic S; Schmidt N; Reifenberger G; Riemenschneider MJ
Acta Neuropathol; 2011 Aug; 122(2):241-51. PubMed ID: 21590492
[TBL] [Abstract][Full Text] [Related]
35. STAT3-mediated constitutive expression of SOCS3 in an undifferentiated rat trophoblast-like cell line.
Isobe A; Takeda T; Sakata M; Yamamoto T; Minekawa R; Hayashi M; Auernhammer CJ; Tasaka K; Murata Y
Placenta; 2006 Aug; 27(8):912-8. PubMed ID: 16300827
[TBL] [Abstract][Full Text] [Related]
36. Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors.
Dobashi Y; Suzuki S; Sugawara H; Ooi A
Hum Pathol; 2007 Jun; 38(6):914-25. PubMed ID: 17376509
[TBL] [Abstract][Full Text] [Related]
37. Suppressor of cytokine signaling 3 inhibits breast tumor kinase activation of STAT3.
Gao Y; Cimica V; Reich NC
J Biol Chem; 2012 Jun; 287(25):20904-12. PubMed ID: 22547065
[TBL] [Abstract][Full Text] [Related]
38. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes.
Prêle CM; Keith-Magee AL; Yerkovich ST; Murcha M; Hart PH
Immunology; 2006 Sep; 119(1):8-17. PubMed ID: 16925527
[TBL] [Abstract][Full Text] [Related]
39. Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer.
Shang AQ; Wu J; Bi F; Zhang YJ; Xu LR; Li LL; Chen FF; Wang WW; Zhu JJ; Liu YY
Cancer Biol Ther; 2017 May; 18(5):314-322. PubMed ID: 28448787
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of signal transducer and activator of transcription (STAT-3 and STAT-5) transcription factors and alteration of suppressor of cytokine signaling (SOCS-1) protein in prostate cancer.
Singh N; Hussain S; Bharadwaj M; Kakkar N; Singh SK; Sobti RC
J Recept Signal Transduct Res; 2012 Dec; 32(6):321-7. PubMed ID: 23134344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
